Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer

NCT01325142 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT01325142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01325142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
November 30, 2014
Enrollment
271 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bisphosphonate-associated osteonecrosis of the jaw, bone diseases, metastases, osteonecrosis